The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Figure 3. (A) The relationship between sarcopenia and ORR in TAE or TACE treated HCC patients; (B) The relationship between sarcopenia and DCR in TAE or TACE treated HCC patients.